Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Authorities on Monday released new photos and videos of a person of interest dressed in dark clothing as officials search for the gunman in the deadly attack at Brown University that killed two ...
Generative AI is infiltrating everything you do online, including how you find information. If you're bored with traditional search, check out the top AI search engines we've tried. I’ve been writing ...
Follow ZDNET: Add us as a preferred source on Google. I don't know about you, but I'm tired of seeing AI used in place of actual search results in my web browser or used to summarize whatever I'm ...
The bodies of 13 deceased hostages are believed to still be in Gaza. U.S. officials -- including Vice President JD Vance, Special Envoy Steve Witkoff and Jared Kushner -- traveled to Israel this week ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results